Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Present

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
BMC Medical Genetics|May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control studyInga Peter, Adele A Mitchell, Laurie Ozelius, et al.
The American Journal of Gastroenterology|October 11, 2008
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trialJames F Marion, Jerome D Waye, Daniel H Present, et al.
Gastroenterology|March 8, 2008
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trialJames D Lewis, Gary R Lichtenstein, Julius J Deren, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2015
Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With ColitisJames F Marion, Jerome D Waye, Yuriy Israel, et al.
Gastroenterology|May 9, 2007
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE TrialStephan R Targan, Brian G Feagan, Richard N Fedorak, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
BMC Medical Genetics|May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control studyInga Peter, Adele A Mitchell, Laurie Ozelius, et al.
The American Journal of Gastroenterology|October 11, 2008
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trialJames F Marion, Jerome D Waye, Daniel H Present, et al.
Gastroenterology|March 8, 2008
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trialJames D Lewis, Gary R Lichtenstein, Julius J Deren, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2015
Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With ColitisJames F Marion, Jerome D Waye, Yuriy Israel, et al.
Gastroenterology|May 9, 2007
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE TrialStephan R Targan, Brian G Feagan, Richard N Fedorak, et al.
Pageof 3